Latest Safety News

Clinuvel Pharmaceuticals targets year-end for topline results from its pivotal vitiligo trial of SCENESSE® combined with narrowband UVB, aiming to expand the drug's use beyond its current rare disease indication.

Avira Resources has secured critical approvals and made substantial progress in its 4,500-metre RC drilling program at the Mt Cattlin Gold Project, advancing towards a maiden resource estimate targeted for Q4 2026.

Whitehaven Coal delivered a robust finish to FY26, hitting top-end guidance for production and sales while improving safety and reducing costs.

6K Additive surged to a record US$7.1 million revenue in Q2 2026, driven by strong demand in critical metal powders and backed by robust cash reserves and government contracts.

IGO Limited closed FY26 on a high note with improved safety metrics, rising spodumene prices, and a strategic divestment of its Nova nickel operation. Despite a fire-induced shutdown at Greenbushes, the company maintained robust cash flow and set ambitious FY27 guidance.

Prescient Therapeutics boosted enrolment in its PTX-100 Phase 2a trial to 28 patients and appointed Dr Rosalind Wilson as Chief Medical Officer, strengthening its clinical leadership as it advances targeted cancer therapies.

Arovella Therapeutics secured ethics approval and manufactured its first clinical batch of ALA-101, targeting blood cancers, while progressing its solid tumour program and refining autoimmune strategies. The company ended the quarter with $14.4 million in cash, supporting imminent clinical milestones.

Imugene's azer-cel therapy shows a third patient response in the BTKi combination cohort of its Phase 1b trial, while CEO Leslie Chong steps down after nearly 11 years, prompting a leadership search.

West Wits Mining has achieved a major underground breakthrough at Qala Shallows, unlocking higher-grade ore zones, while completing a comprehensive ZAR 1.115 billion finance package that underpins its production ramp-up.

Syntara secured positive FDA feedback for its Phase 2b amsulostat trial in myelofibrosis and raised $8 million to extend its cash runway to Q3 2027, while preliminary data showed promising brain inflammation reduction in a Parkinson’s-related disorder.

Acusensus has won a A$4.3 million contract extension with Queensland’s Department of Transport and Main Roads for its mobile phone and seatbelt detection technology, extending service through November 2027.

Conrad Asia Energy has locked in over 90% of its US$320 million Mako Gas Project contracts, maintaining its timeline for first gas in late 2027 while restructuring leadership and progressing Aceh PSC assets.